Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

The combination treatment showed a higher response rate but no significant survival benefits.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Patients with renal disease should be cautious with vitamin A supplements due to risk of toxicity.

A man developed a unique rash on his neck after taking niacinamide, and doctors recommend considering niacinamide as a cause for similar rashes and using dermatoscopy for diagnosis.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.